Reuters logo
BRIEF-Nexstim receives FDA's nod for proposed limited size stroke trial plan
December 21, 2016 / 3:13 PM / 9 months ago

BRIEF-Nexstim receives FDA's nod for proposed limited size stroke trial plan

Dec 21 (Reuters) - Nexstim Oyj :

* Nexstim PLC receives FDA’s response to the proposed limited size stroke trial plan

* FDA’s response was positive and provides Nexstim possibility to start new 60 patient trial in Q1 2017

* According to FDA recommendation data from new trial will be combined with data from previous phase III trial

* Nexstim expects that the E-FIT trial will be completed in Q1 2018 Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below